Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GI-4000 in resected pancreatic cancer
NCT00300950Phase 2Completed
- Sponsor
- GlobeImmune
- Start
- Jan 2006
- Primary completion
- Feb 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of GI-4000 in pancreatic cancer (PC), sponsored by GlobeImmune. Started Jan 2006; status: completed.
02
Drugs
GI-4000
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00300950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00300950.